Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2019				62,574,961	62,574,961
Beginning balance at Dec. 31, 2019	$ 1,782,485	$ (34)	$ 1,782,451	$ 626	$ 626	$ 1,348,733	$ 1,348,733	$ 433,126	$ (34)	$ 433,092
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	36,760							36,760
Shares issued under stock-based compensation programs, net (in shares)				477,582
Shares issued under stock-based compensation programs, net	8,194			$ 5		8,189
Cash dividends declared	(20,768)							(20,768)
Stock-based compensation expense	4,440					4,440
Forfeiture of restricted stock (in shares)				(48)
Ending balance (in shares) at Mar. 31, 2020				63,052,495
Ending balance at Mar. 31, 2020	$ 1,811,077			$ 631		1,361,362		449,084
Beginning balance (in shares) at Dec. 31, 2020	64,851,126			64,851,126
Beginning balance at Dec. 31, 2020	$ 2,119,912			$ 649		1,407,597		711,666
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	110,690							110,690
Shares issued under stock-based compensation programs, net (in shares)				221,303
Shares issued under stock-based compensation programs, net	1,009			$ 2		1,007
Cash dividends declared	(25,978)							(25,978)
Stock dividend declared (in shares)				5,192,776
Stock dividend declared	(687)			$ 52		279,579		(280,318)
Stock-based compensation expense	$ 9,926					9,926
Ending balance (in shares) at Mar. 31, 2021	70,265,205			70,265,205
Ending balance at Mar. 31, 2021	$ 2,214,872			$ 703		$ 1,698,109		$ 516,060